Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 34.46%4.85M | -106.92%-234K | 4.51%5.61M | 3.44%13.18M | -90.34%822K | 951.60%3.61M | 13.71%3.38M | 488.06%5.37M | 121.54%12.74M | 815.90%8.51M |
| Net income from continuing operations | -211.75%-2.06M | -121.26%-710K | -98.87%41K | 140.16%8.27M | 97.45%-542K | 86.94%1.85M | 4,802.82%3.34M | 1,400.36%3.63M | -544.29%-20.6M | -1,005.47%-21.24M |
| Operating gains losses | 133.49%220K | 99.94%-1K | -400.00%-60K | -110.46%-2.09M | 195.37%103K | -3,357.89%-657K | -108.29%-1.56M | 116.81%20K | -326.94%-994K | -110.06%-108K |
| Depreciation and amortization | 59.78%4.02M | 48.71%2.65M | 7.73%2.43M | 58.11%9.5M | 48.66%2.95M | 56.66%2.52M | 71.18%1.78M | 63.54%2.25M | 38.68%6.01M | 62.17%1.99M |
| Asset impairment expenditure | --0 | --0 | --0 | -87.57%2.66M | -89.85%2.17M | -150.00%-9K | -257.14%-22K | 3,393.33%524K | 10,868.72%21.39M | 152,342.86%21.34M |
| Remuneration paid in stock | -51.93%361K | -126.86%-83K | -59.10%164K | 27.84%1.59M | -69.38%128K | 254.25%751K | 22.62%309K | 11.08%401K | -7.31%1.24M | 12.97%418K |
| Deferred tax | -42.54%-2.12M | -1,908.00%-904K | 94.73%-39K | -150.23%-3.41M | -115.32%-1.23M | -272.00%-1.49M | 113.05%50K | -65.55%-740K | 678,000.00%6.78M | 3,110.90%8.01M |
| Other non cashItems | 398.44%319K | 607.35%481K | -15.79%48K | 328.57%224K | -55.70%35K | 137.04%64K | 168.69%68K | 154.29%57K | -122.74%-98K | -59.69%79K |
| Change In working capital | 605.83%4.12M | -184.96%-1.67M | 492.11%3.03M | -261.40%-3.57M | -41.22%-2.79M | 127.91%583K | -119.70%-585K | -802.73%-773K | -144.62%-987K | -5.16%-1.98M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 34.46%4.85M | -106.92%-234K | 4.51%5.61M | 3.44%13.18M | -90.34%822K | 951.60%3.61M | 13.71%3.38M | 488.06%5.37M | 121.54%12.74M | 815.90%8.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -89.95%-7.71M | -171.26%-30.02M | -136.03%-4.76M | 2.34%-20.62M | -46.73%-3.48M | 15.94%-4.06M | -19.59%-11.07M | 56.77%-2.02M | -28.16%-21.12M | -36.74%-2.37M |
| Capital expenditure reported | ---- | 22.23%-4.26M | ---- | -1,626.39%-22.63M | ---- | ---- | -1,512.65%-5.48M | ---- | ---1.31M | ---- |
| Net PPE purchase and sale | -251.68%-9.2M | -558.33%-395K | 44.22%-6.67M | ---- | ---- | -2,256.76%-2.62M | 98.75%-60K | -32.63%-11.96M | -67.25%-18.95M | -82.16%-18.23M |
| Net business purchase and sale | --0 | ---28.4M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | 203.05%1.49M | 155.06%3.04M | -80.73%1.92M | 110.16%2.01M | 55.11%-799K | 69.40%-1.44M | -34.12%-5.52M | 128.25%9.95M | -284.84%-19.8M | -121.52%-1.78M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -89.95%-7.71M | -171.26%-30.02M | -136.03%-4.76M | 2.34%-20.62M | -46.73%-3.48M | 15.94%-4.06M | -19.59%-11.07M | 56.77%-2.02M | -28.16%-21.12M | -36.74%-2.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 26,626.47%9.09M | 498.70%30.95M | 9.66%-1.88M | 4,465.38%5.94M | 262.39%2.81M | 101.81%34K | -7.70%5.17M | -11.47%-2.08M | -98.56%130K | -116.16%-1.73M |
| Net issuance payments of debt | 10,984.34%9.03M | 440.28%27.67M | 5.73%-2.01M | 1,702.92%5.55M | 273.08%2.64M | 95.78%-83K | -8.45%5.12M | -18.61%-2.13M | 109.61%308K | -3.95%-1.53M |
| Net common stock issuance | --0 | 1,346.26%5.22M | ---- | 97.62%415K | --0 | -61.70%54K | 423.19%361K | ---- | -98.34%210K | --0 |
| Net other financing activities | -15.87%53K | -520.13%-1.94M | 161.22%128K | 91.49%-33K | 182.35%168K | 226.00%63K | -396.83%-313K | 169.01%49K | 4.20%-388K | -137.21%-204K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 26,626.47%9.09M | 498.70%30.95M | 9.66%-1.88M | 4,465.38%5.94M | 262.39%2.81M | 101.81%34K | -7.70%5.17M | -11.47%-2.08M | -98.56%130K | -116.16%-1.73M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.30%6.34M | -40.04%5.72M | -17.62%6.74M | -49.89%8.19M | 72.61%6.55M | -31.05%6.99M | -12.17%9.54M | -49.89%8.19M | -8.93%16.34M | -56.55%3.79M |
| Current changes in cash | 1,585.68%6.23M | 127.89%701K | -180.38%-1.02M | 81.75%-1.5M | -96.51%154K | 93.41%-419K | -271.20%-2.51M | 122.69%1.27M | -392.94%-8.24M | -43.40%4.41M |
| Effect of exchange rate changes | 645.45%120K | -132.35%-79K | -102.60%-2K | -33.33%62K | 327.78%41K | -229.41%-22K | 22.73%-34K | -44.20%77K | 30.99%93K | 90.43%-18K |
| End cash Position | 93.69%12.69M | -9.30%6.34M | -40.04%5.72M | -17.62%6.74M | -17.62%6.74M | 72.61%6.55M | -31.05%6.99M | -12.17%9.54M | -49.89%8.19M | -49.89%8.19M |
| Free cash from | -538.95%-4.35M | -126.53%-4.89M | 83.89%-1.06M | -182.68%-9.45M | -123.46%-1.86M | 327.16%991K | 0.00%-2.16M | 18.67%-6.59M | 304.95%11.43M | 170.75%7.92M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.